HRT Financial’s Lesaka Technologies LSAK Stock Holding History

HRT Financial’s Portfolio LSAK Stock Details LSAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,599	Closed	-$130K	–	3524
2021 Q4	$130K	Buy	+24,599	New	+$127K	﹤0.01%	2688

Other funds holding LSAK

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

Hosking Partners London, United Kingdom $2.79B AUM 58.33% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

HRT Financial's LSAK Position: Q1 2022 in Review

HRT Financial sold out of Lesaka Technologies (LSAK) in Q1 2022, closing a stake of 24,599 shares — an estimated $130K sold.

HRT Financial first reported a position in LSAK in Q4 2021 and held it in 1 quarter. The position peaked at $130K in Q4 2021. 34 funds tracked by Wall St. Rank hold LSAK as of Q1 2022.

HRT Financial reported no remaining Lesaka Technologies position as of Q1 2022 after selling out during the quarter.
HRT Financial sold 24,599 Lesaka Technologies shares in Q1 2022, an estimated $130K.
HRT Financial first reported a position in Lesaka Technologies in Q4 2021 and held it in 1 quarter.
HRT Financial's Lesaka Technologies position peaked at $130K in Q4 2021.
34 funds tracked by Wall St. Rank held Lesaka Technologies as of Q1 2022.

Based on HRT Financial's 13F filing for Q1 2022, filed 16 May 2022.